Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 48

Sort by

Sort Order Select

Journal Articles

T-cell immune responses to Wilms tumor 1 protein in myelodysplasia responsive to immunosuppressive therapy

Elaine M. Sloand, J. Joseph Melenhorst, Zachary C. G. Tucker, Loretta Pfannes, Jason M. Brenchley, Agnes Yong, Valeria Visconte, Colin Wu, Emma Gostick, Phillip Scheinberg, Matthew J. Olnes, Daniel C. Douek, David A. Price, A. John Barrett, Neal S. Young

Blood (2011) 117 (9): 2691–2699.

https://doi.org/10.1182/blood-2010-04-277921

Published: 2011

Includes: Supplemental data

Journal Articles

A Randomized Trial of Horse Versus Rabbit Antithymocyte Globulin In Severe Acquired Aplastic Anemia

Phillip Scheinberg, MD, Colin O Wu, PhD, Priscila Scheinberg, MS, Barbara Weinstein, RN, Olga Nunez, RN, Elaine M Sloand, MD, Neal S. Young, MD

Blood (2010) 116 (21): LBA-4.

https://doi.org/10.1182/blood.V116.21.LBA-4.LBA-4

Published: 2010

Journal Articles

JAK2 Inhibition with TG101348 Inhibits Monosomy 7 Myelodysplastic Syndromes (MDS) Bone Marrow Cells In Vitro: a Potential Targeted Therapy for Monosomy 7 MDS

Matthew J. Olnes, MD, PhD, Andrea Poon, BS, Zachary Tucker, BS, Neal S. Young, MD, Elaine M Sloand, MD

Blood (2010) 116 (21): 973.

https://doi.org/10.1182/blood.V116.21.973.973

Published: 2010

Journal Articles

Does a Chronic Inflammatory Process Underlie Clonal Progression In Aplastic Anemia?- In Vitro and In Vivo Evidence That Inflammation Produces Aneuploidy for Chromosomes 7 and 8 In Replicating Cells

Elaine M Sloand, MD, Kelsey Loeliger, BA, Loretta Pfannes, BA, Andrea Poon, BS, Rodrigo Calado, MD, PhD, Xingmin Feng, PhD, Hesed Padilla-Nash, Jichun Chen, PhD, Neal S. Young, MD

Blood (2010) 116 (21): 641.

https://doi.org/10.1182/blood.V116.21.641.641

Published: 2010

Journal Articles

Pure Red Cell Aplasia Associated with Plasma Cell Myeloma: Does Monoclonal Protein Inhibit Erythropoiesis?

Neha Korde, MD, Kelsey Loeliger, BA, Olga Simakova, PhD, Adriana Zingone, PhD, Richard Childs, MD, Ola Landgren, MD, PhD, Pierre Noel, MD, Elaine M Sloand, MD, Irina Maric, MD

Blood (2010) 116 (21): 642.

https://doi.org/10.1182/blood.V116.21.642.642

Published: 2010

Journal Articles

Overall Survival In Myelodysplastic Syndrome or Acute Myeloid Leukemia Patients Treated with On 01910.Na Correlates with Bone Marrow Blast Response

Lewis R Silverman, MD, Azra Raza, MD, Elaine M Sloand, MD, Peter L. Greenberg, MD, Francois E Wilhelm, MD, PhD

Blood (2010) 116 (21): 3998.

https://doi.org/10.1182/blood.V116.21.3998.3998

Published: 2010

Journal Articles

Eltrombopag Can Stimulate Trilineage Hematopoiesis In Patients with Refractory Severe Aplastic Anemia

Matthew J. Olnes, MD, PhD, Yong Tang, MD, Susan Soto, RN, Elaine M Sloand, MD, Philip Scheinberg, MD, Neal S. Young, MD, Cynthia E. Dunbar, MD

Blood (2010) 116 (21): 4427.

https://doi.org/10.1182/blood.V116.21.4427.4427

Published: 2010

Journal Articles

Killing of Quiescent and Cycling Chronic Myeloid Leukemia CD34+ Cells by Autologous Ex-Vivo Expanded Natural Killer Cells Is Enhanced by Bortezomib Treatment.

Agnes S.M. Yong, MD, PhD, Nicole Stephens, BS, Keyvan Keyvanfar, BS, Bipin N. Savani, MD, Rhoda Eniafe, BS, Maria Berg, BS, Elaine M. Sloand, MD, Richard Childs, MD, A. John Barrett, MD

Blood (2010) 116 (21): 3395.

https://doi.org/10.1182/blood.V116.21.3395.3395

Published: 2010

Journal Articles

Alemtuzumab (Campath) Monotherapy for Severe Aplastic Anemia.

Phillip Scheinberg, MD, Colin O Wu, PhD, Priscila Scheinberg, MS, CCRP, Olga Nunez, RN, Elaine M Sloand, MD, Neal S. Young, MD

Blood (2010) 116 (21): 1167.

https://doi.org/10.1182/blood.V116.21.1167.1167

Published: 2010

Journal Articles

ON 01910.Na Suppresses Cyclin D1 Accumulation in trisomy 8 Myelodysplastic Syndromes Patients While Decreasing Bone Marrow CD34+ Blast Counts and Aneuploid Clone Size.

Elaine M Sloand, MD, Matthew J. Olnes, MD, PhD, Naomi Galili, PhD, Aarthi Shenoy, MD, Loretta Pfannes, Francois Wilhelm, MD, Ph.D, Barbara Weinstein, Phillip Scheinberg, MD, Jerome E. Groopman, MD, Azra Raza

Blood (2009) 114 (22): 120.

https://doi.org/10.1182/blood.V114.22.120.120

Published: 2009

Journal Articles

Alemtuzumab Treatment of Intermediate-1 (INT-1) Myelodysplasia Patients Is Associated with Sustained Improvement in Blood Counts and Cytogenetic Remissions.

Elaine M Sloand, MD, Matthew J. Olnes, MD, PhD, Barbara Weinstein, Phillip Scheinberg, MD, Neal S Young, MD

Blood (2009) 114 (22): 116.

https://doi.org/10.1182/blood.V114.22.116.116

Published: 2009

Journal Articles

Telomere Shortening Promotes Chromosomal Instability and Predicts Malignant Clonal Evolution in Aplastic Anemia.

Rodrigo T. Calado, MD, PhD, James N Cooper, B.A., Phillip Scheinberg, MD, Colin Wu, Marco A Zago, MD, PhD, Hesed Padilla-Nash, PhD, Thomas Ried, MD, Elaine M Sloand, MD, Neal S Young, MD

Blood (2009) 114 (22): 3208.

https://doi.org/10.1182/blood.V114.22.3208.3208

Published: 2009

Journal Articles

Effects of Granulocyte Colony Stimulating Factor (G-CSF) On Monosomy 7 Aneuploidy and T Cell Subsets in Healthy Donors.

Matthew J. Olnes, MD, PhD, Susan Leitman, MD, Angelique Biancotto, PhD, J. Philip McCoy, Jr., PhD, Susan Miranda, BA, Zachary Tucker, BA, Loretta Pfannes, BS, Megan Furnari, Neal S Young, MD, Elaine M Sloand, MD

Blood (2009) 114 (22): 3147.

https://doi.org/10.1182/blood.V114.22.3147.3147

Published: 2009

Journal Articles

Primitive quiescent CD34 + cells in chronic myeloid leukemia are targeted by in vitro expanded natural killer cells, which are functionally enhanced by bortezomib

Agnes S. M. Yong, Keyvan Keyvanfar, Nancy Hensel, Rhoda Eniafe, Bipin N. Savani, Maria Berg, Andreas Lundqvist, Sharon Adams, Elaine M. Sloand, John M. Goldman, Richard Childs, A. John Barrett

Blood (2009) 113 (4): 875–882.

https://doi.org/10.1182/blood-2008-05-158253

Published: 2009

Journal Articles

Inflammation Caused by Allogeneic Lymphocytes Results in Aneuploidy in Bone Marrow Mononuclear Cells (BMMNC)

Elaine M Sloand, MD, Hesed Padilla-Nash, PhD, Megan Furnari, Rodrigo Calado, MD, PhD, Ling Casey, Thomas Reid, MD, PhD, Neal S Young, MD

Blood (2008) 112 (11): 3112.

https://doi.org/10.1182/blood.V112.11.3112.3112

Published: 2008

Journal Articles

Suppression of Cyclin D 1 (CD1) by on 01910.Na Is Associated with Decreased Survival or Trisomy 8 Myelodysplastic Bone Marrow: A Potential Targetted Therapy for Trisomy 8 MDS.

Aarthi Shenoy, MD, Loretta Pfannes, Francois Wilhelm, MD, Ph.D, Manoj Maniar, Ph.D, Neal Young, MD, Elaine M Sloand, MD

Blood (2008) 112 (11): 1651.

https://doi.org/10.1182/blood.V112.11.1651.1651

Published: 2008

Journal Articles

Altered Naive and Memory T Cell Homeostasis and Immunosenescence Characterize Younger Patients with Immunosuppressive-Responsive Myelodysplastic Syndrome

JianXiang Zou, MD, Dana E Rollison, PhD, David Boulware, MS, Elaine M. Sloand, MD, Loretta Pfannes, BS, Fanqi Bai, MD, Jeffrey S. Painter, BS, Sheng Wei, MD, Denise Cosgrove, RN, Alan F. List, MD, P.K. Epling-Burnette, PhD

Blood (2008) 112 (11): 3647.

https://doi.org/10.1182/blood.V112.11.3647.3647

Published: 2008

Journal Articles

Monosomy 7 Detected by FISH at Disease Presentation Is a Marker for Non-Response to Immunosuppression.

Elaine Sloand, MD, Phillip Scheinberg, MD, Edward Fenlon, Jan Blancato, PhD, Loretta Pfannes, Elaine M. Sloand, MD, Neal S. Young, MD

Blood (2007) 110 (11): 1697.

https://doi.org/10.1182/blood.V110.11.1697.1697

Published: 2007

Journal Articles

Primitive Quiescent CD34+ Cells in Chronic Myeloid Leukemia Are Targeted by In Vitro Expanded Allogeneic Natural Killer Cells, Which Are Functionally Enhanced by Bortezomib Treatment.

Agnes S.M. Yong, MD, PhD, Keyvan Keyvanfar, BS, Nancy Hensel, BS, Rhoda Eniafe, BS, Bipin N. Savani, MD, Maria Berg, BS, Andreas Lundqvist, PhD, Elaine M. Sloand, MD, John M. Goldman, MD, Richard W. Childs, MD, A. John Barrett, MD

Blood (2007) 110 (11): 1008.

https://doi.org/10.1182/blood.V110.11.1008.1008

Published: 2007

Journal Articles

Suppression of Cyclin D1 by on 01910.Na Is Associated with Decreased Survival of Trisomy 8 Myelodyplastic Bone Marrow Progenitors: A Potential Targetted Therapy.

Elaine M. Sloand, MD, Loretta Pfannes, Ramana Reddy, PhD, Premkumar Reddy, PhD, Jerome S. Groopman, MD, Neal S. Young, MD

Blood (2007) 110 (11): 822.

https://doi.org/10.1182/blood.V110.11.822.822

Published: 2007

NARROW

T-cell immune responses to Wilms tumor 1 protein in myelodysplasia responsive to immunosuppressive therapy

A Randomized Trial of Horse Versus Rabbit Antithymocyte Globulin In Severe Acquired Aplastic Anemia

JAK2 Inhibition with TG101348 Inhibits Monosomy 7 Myelodysplastic Syndromes (MDS) Bone Marrow Cells In Vitro: a Potential Targeted Therapy for Monosomy 7 MDS

Does a Chronic Inflammatory Process Underlie Clonal Progression In Aplastic Anemia?- In Vitro and In Vivo Evidence That Inflammation Produces Aneuploidy for Chromosomes 7 and 8 In Replicating Cells

Pure Red Cell Aplasia Associated with Plasma Cell Myeloma: Does Monoclonal Protein Inhibit Erythropoiesis?

Overall Survival In Myelodysplastic Syndrome or Acute Myeloid Leukemia Patients Treated with On 01910.Na Correlates with Bone Marrow Blast Response

Eltrombopag Can Stimulate Trilineage Hematopoiesis In Patients with Refractory Severe Aplastic Anemia

Killing of Quiescent and Cycling Chronic Myeloid Leukemia CD34+ Cells by Autologous Ex-Vivo Expanded Natural Killer Cells Is Enhanced by Bortezomib Treatment.

Alemtuzumab (Campath) Monotherapy for Severe Aplastic Anemia.

ON 01910.Na Suppresses Cyclin D1 Accumulation in trisomy 8 Myelodysplastic Syndromes Patients While Decreasing Bone Marrow CD34+ Blast Counts and Aneuploid Clone Size.

Alemtuzumab Treatment of Intermediate-1 (INT-1) Myelodysplasia Patients Is Associated with Sustained Improvement in Blood Counts and Cytogenetic Remissions.

Telomere Shortening Promotes Chromosomal Instability and Predicts Malignant Clonal Evolution in Aplastic Anemia.

Effects of Granulocyte Colony Stimulating Factor (G-CSF) On Monosomy 7 Aneuploidy and T Cell Subsets in Healthy Donors.

Primitive quiescent CD34 + cells in chronic myeloid leukemia are targeted by in vitro expanded natural killer cells, which are functionally enhanced by bortezomib

Inflammation Caused by Allogeneic Lymphocytes Results in Aneuploidy in Bone Marrow Mononuclear Cells (BMMNC)

Suppression of Cyclin D 1 (CD1) by on 01910.Na Is Associated with Decreased Survival or Trisomy 8 Myelodysplastic Bone Marrow: A Potential Targetted Therapy for Trisomy 8 MDS.

Altered Naive and Memory T Cell Homeostasis and Immunosenescence Characterize Younger Patients with Immunosuppressive-Responsive Myelodysplastic Syndrome

Monosomy 7 Detected by FISH at Disease Presentation Is a Marker for Non-Response to Immunosuppression.

Primitive Quiescent CD34+ Cells in Chronic Myeloid Leukemia Are Targeted by In Vitro Expanded Allogeneic Natural Killer Cells, Which Are Functionally Enhanced by Bortezomib Treatment.

Suppression of Cyclin D1 by on 01910.Na Is Associated with Decreased Survival of Trisomy 8 Myelodyplastic Bone Marrow Progenitors: A Potential Targetted Therapy.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only